Monte Rosa Therapeutics, Inc. (GLUE)
13.84
-0.54
(-3.76%)
USD |
NASDAQ |
Sep 04, 16:00
13.97
+0.13
(+0.94%)
After-Hours: 20:00
Monte Rosa Therapeutics SG&A Expense (TTM) : 39.89M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 39.89M |
| March 31, 2026 | 37.85M |
| December 31, 2025 | 36.38M |
| September 30, 2025 | 34.64M |
| June 30, 2025 | 33.70M |
| March 31, 2025 | 34.89M |
| December 31, 2024 | 35.17M |
| September 30, 2024 | 34.12M |
| June 30, 2024 | 34.66M |
| March 31, 2024 | 33.52M |
| December 31, 2023 | 32.04M |
| September 30, 2023 | 31.93M |
| June 30, 2023 | 30.29M |
| Date | Value |
|---|---|
| March 31, 2023 | 28.44M |
| December 31, 2022 | 27.32M |
| September 30, 2022 | 24.96M |
| June 30, 2022 | 22.69M |
| March 31, 2022 | 19.88M |
| December 31, 2021 | 15.73M |
| September 30, 2021 | 10.47M |
| June 30, 2021 | 6.631M |
| March 31, 2021 | 3.686M |
| December 31, 2020 | 1.933M |
| September 30, 2020 | 1.933M |
| June 30, 2020 | 1.019M |
| March 31, 2020 | 0.478M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Nurix Therapeutics, Inc. | 57.01M |
| Gilead Sciences, Inc. | 9.147B |
| Ironwood Pharmaceuticals, Inc. | 64.55M |
| Capricor Therapeutics, Inc. | 35.43M |
| Cue Biopharma, Inc. | 59.11M |